A groundbreaking clinical trial has begun, treating its first participant with a novel cellular reprogramming therapy designed to reverse the aging process in cells. This pioneering approach aims to rejuvenate cells, marking a significant step in the field of longevity research. The trial represents a world-first application of this technology in a human subject. AI
RANK_REASON The cluster describes a novel research trial involving a new therapy. [lever_c_demoted from research: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →